Genomic characteristics of deleterious BRCA1 and BRCA2 alterations and associations with baseline clinical factors in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in TRITON2.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Wassim Abida, Alan Haruo Bryce, Nicholas J. Vogelzang, Robert J. Amato, Ivor John Percent, Jeremy David Shapiro, Raymond S. McDermott, Arif Hussain, Akash Patnaik, Daniel Peter Petrylak, Charles J. Ryan, Thomas S. Stanton, Jingsong Zhang, Andrea Loehr, Andrew Simmons, Darrin Despain, Anthony A. Golsorkhi, Simon Paul Watkins, Howard I. Scher, Simon Chowdhury
Institutions: Memorial Sloan Kettering Cancer Center, Mayo Clinic Hospital, Comprehensive Cancer Centers of Nevada, The University of Texas Health Science Center at Houston, Florida Cancer Specialists & Research Institute, Cabrini Hospital, Tallaght University Hospital, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Chicago, University of Chicago Medicine Comprehensive Cancer Center, Yale Cancer Center, Yale University, University of Minnesota, St. Joseph Health System, Moffitt Cancer Center, Clovis Oncology (United States), Guy's Hospital, Sarah Cannon Research Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2945184947